Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
02192 醫脈通科技
Medlive Technology
Listing Date2021/07/15
Listing Price27.200
Subscription Result
  • Subscription Rate
  • Guarantee One Lot Size
    90 lot
  • One Lot Success Rate

Medlive Technology is the largest online professional physician platform in China. As of December 31, 2020, its Medlive platformhad approximately 3.5 million registered users, around 2.4 million of whom were licensed physicians, representing approximately 58% of all licensed physicians in China as of the same date, according to the Frost & Sullivan Report. In the fourth quarter of 2020, the average MAUs on the platform exceeded 1 million.

Its Medlive platform allows platform participants to gather, learn and connect. The platform participants include physicians, pharmaceutical and medical device companies and patients.

Its solutions are divided into three solution categories, namely, precision marketing and corporate solutions, medical knowledge solutions and intelligent patient management solutions. It derives most of revenue from precision marketing solutions, which offer digital healthcare marketing services to pharmaceutical and medical device companies. Revenue from precision marketing solutions is derived from fees paid by pharmaceutical and medical device companies for digital detailing, digital marketing consulting and digital content creation services. Digital detailing accounts for most of the revenue from precision marketing solutions. It charges pharmaceutical and medical device companies for digital detailing primarily on a cost-per-click basis.

MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaChina
Board Lot500
No. of Offer Shares155m shares
No. of International Offer Shares140m shares
No. of HK Offer Shares15.51m shares
Offer Price$24.10 - $27.20
Registrar & Transfer OfficeTricor Investor Services
Stock Code2192
Sponsor(s)Goldman Sachs (Asia) L.L.C.; Haitong International Capital Limited
Underwriter(s)Goldman Sachs (Asia) L.L.C.; Haitong International Securities Company Limited; China International Capital Corporation Hong Kong Securities Limited
Application PeriodJun 30 (Wed) - Noon, Jul 7 (Wed)
Price Determination DateOn or Before 5pm, Jul 7 (Wed)
Result Announcement DateOn or Before Jul 14 (Wed)
Dispatch of Shares and Refund ChequesOn or Before Jul 14 (Wed)
Dealings in Shares commence onJul 15, 2021. (Thu)
Reallocation of Shares Offered
Times of HK Offer Shares Subscription15X - 50X50X - 100XOver 100X
% of total shares reallocated to HK Offer30%40%50%
ExecutiveTian Liping (Chairman), Tian Lixin, Tian Lijun, Zhou Xin
Non-ExecutiveEiji Tsuchiya, Li Zhuolin
Independent Non-ExecutiveRichard Yeh, Ma Jun, Wang Shan
Director Tian Liping38.8%
(Year ended Dec 31)
Gross Profit156,23677,19049,890
Pre-Taxed Profit104,84836,99816,020
Attributable Profit for the period85,19731,27014,189
Offer Price$24.10 - $27.20
Capitalization$16,633m - $18,723m
Unaudited pro forma adj NAV / share$5.39 - $6.06
Assuming the offer price being at the mid-point of $25.65, the net proceeds raised would be HK$3,770.8m, of which:
* $1,508.3m (40.0%) to business expansion including developing and enhancing our solution offerings;
* $1,131.2m (30.0%) to invest in technology and enhance research and development capabilities;
* $754.2m (20.0%) to pursue strategic investments or acquisitions opportunities; and
* the balance of $377.1m (10.0%) as additional working capital.
Code Name Nominal Change %Change
00241ALI HEALTHdown10.640-0.240-2.206%
01833PA GOODDOCTORup51.8500.2500.484%
06618JD HEALTHup74.4000.5500.745%
15-min delayed, last updated: 15/10/2021 17:59
Related Document
Remark: The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
Subscribing Lot :
Subscribing Fee :

Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.